Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01148914 · ClinicalTrials.gov registry record

The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

A clinical trial, sponsored by Texas Cardiac Arrhythmia Research Foundation.

Completed
Registry status
48
Enrollment target

NCT01148914: Completed study, sponsored by Texas Cardiac Arrhythmia Research Foundation.

NCT01148914 is a clinical trial that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01148914 has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.

COMPLETED
Registry status
48 participants
Enrollment target

Study Summary

This prospective study aims; 1. To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome 2. To evaluate the inflammatory activation following catheter ablation by measuring serum-biomarker levels 24-hours after the procedure and examine the predictive role in procedure success 3. To determine if a change in the baseline level of certain inflammatory biomarkers at 3-months post-ablation period has any correlation with the long-term outcome in patients with atrial fibrillation 4. To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)

Interventions

  • OTHER Inflammatory biomarkers

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2010-06
Est. Completion 2012-04

What the finished NCT01148914 record still lists

NCT01148914 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Inflammatory biomarkers is the first listed.

NCT01148914 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01148914 about?

NCT01148914 is a clinical study titled "The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation". This prospective study aims; 1. To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome 2. To evaluate the inflammatory activation following catheter ablation by measuring serum-biomarker levels 24-hours after the procedure and examine the pr...

What is the current status of trial NCT01148914?

This trial is currently completed. The enrollment target is 48 participants. The study started on 2010-06. Estimated completion is 2012-04.

What interventions are being tested in trial NCT01148914?

The interventions under investigation include: Inflammatory biomarkers (OTHER).

Who is sponsoring clinical trial NCT01148914?

This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01148914, the US trial registry maintained by the National Library of Medicine. NCT01148914 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.